GLP-1 THERAPY

GLP-1 therapy uses medications that work with the body's natural appetite and metabolic pathways. These treatments may help reduce hunger, improve feelings of fullness, and support weight loss when used as part of a physician-guided treatment plan.

DHmeds offers Semaglutide and Tirzepatide for appropriate patients. Dr. Hirsch will review your health history, goals, and individual needs to help determine which option may be most appropriate for you.

Semaglutide works primarily through the GLP-1 receptor, while Tirzepatide works through both GLP-1 and GIP receptors. Both may support appetite regulation and weight management, but they are different medications and individual responses can vary.

GLP-1 therapy may be appropriate for adults who are overweight or have obesity and would benefit from physician-guided medical weight management. Eligibility depends on your health history, medications, goals, and other individual factors.

Weight-loss results vary from person to person. Your starting weight, medication, dose, lifestyle, treatment duration, and individual response can all affect your progress. Dr. Hirsch monitors your treatment and makes adjustments when appropriate.

Possible side effects can include nausea, constipation, diarrhea, decreased appetite, or other gastrointestinal symptoms. Dr. Hirsch will discuss potential risks, side effects, and whether treatment is appropriate for you during your consultation.

Not necessarily. DHmeds offers statewide Florida telehealth, allowing eligible Florida patients to complete consultations and receive ongoing physician-guided care remotely.

There is no single medication that is best for everyone. Dr. Hirsch considers your health history, previous weight-loss experience, goals, treatment preferences, and response to therapy when recommending an individualized treatment plan.